Literature DB >> 25024200

Caspase-8 promotes NLRP1/NLRP3 inflammasome activation and IL-1β production in acute glaucoma.

Wei Chi1, Fei Li1, Hongrui Chen1, Yandong Wang1, Yingting Zhu1, Xuejiao Yang1, Jie Zhu2, Frances Wu2, Hong Ouyang2, Jian Ge1, Robert N Weinreb2, Kang Zhang3, Yehong Zhuo4.   

Abstract

Acute glaucoma is a sight-threatening condition characterized by a sudden and substantial rise in intraocular pressure (IOP) and consequent retinal ganglion cell (RGC) death. Angle closure glaucoma, a common cause of glaucoma in Asia that affects tens of millions of people worldwide, often presents acutely with loss of vision, pain, and high IOP. Even when medical and surgical treatment is available, acute angle closure glaucoma can cause permanent and irreversible loss of vision. Toll-like receptor 4 (TLR4) signaling has been previously implicated in the pathogenesis of IOP-induced RGC death, although the underlying mechanisms are largely unknown. In the present study, we used an acute IOP elevation/glaucoma model to investigate the underlying mechanism of RGC death. We found that TLR4 leads to increased caspase-8 expression; this elevation increases IL-1β expression and RGC death via a caspase-1-dependent pathway involving Nod-like receptor family, pyrin domain containing 1 (NLRP1)/NLRP3 inflammasomes and a caspase-1-independent pathway. We show that inhibition of caspase-8 activation significantly attenuates RGC death by down-regulating the activation of NLRP1 and NLRP3, thus demonstrating the pivotal role of caspase-8 in the TLR4-mediated activation of inflammasomes. These findings demonstrate collectively a critical role of caspase-8 in transducing TLR4-mediated IL-1β production and RGC death and highlight signal transduction in a caspase-1-dependent NLRP1/NLRP3 inflammasome pathway and a caspase-1-independent pathway in acute glaucoma. These results provide new insight into the pathogenesis of glaucoma and point to a treatment strategy.

Entities:  

Keywords:  cell apoptosis; retinal ischemia/reperfusion injury

Mesh:

Substances:

Year:  2014        PMID: 25024200      PMCID: PMC4121847          DOI: 10.1073/pnas.1402819111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Heterogeneous populations of microglia/macrophages in the retina and their activation after retinal ischemia and reperfusion injury.

Authors:  Cheng Zhang; Tim T Lam; Mark Om Tso
Journal:  Exp Eye Res       Date:  2005-06-20       Impact factor: 3.467

Review 2.  Inflammasome signaling at the heart of central nervous system pathology.

Authors:  Swarupa Chakraborty; Deepak Kumar Kaushik; Malvika Gupta; Anirban Basu
Journal:  J Neurosci Res       Date:  2010-06       Impact factor: 4.164

Review 3.  Regulation of microglia activation and deactivation by nuclear receptors.

Authors:  Kaoru Saijo; Andrea Crotti; Christopher K Glass
Journal:  Glia       Date:  2012-09-17       Impact factor: 7.452

4.  Essential role for caspase-8 in Toll-like receptors and NFkappaB signaling.

Authors:  Bénédicte Lemmers; Leonardo Salmena; Nicolas Bidère; Helen Su; Elzbieta Matysiak-Zablocki; Kiichi Murakami; Pamela S Ohashi; Andrea Jurisicova; Michael Lenardo; Razqallah Hakem; Anne Hakem
Journal:  J Biol Chem       Date:  2007-01-09       Impact factor: 5.157

5.  Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice.

Authors:  Can-Xiang Cao; Qing-Wu Yang; Feng-Lin Lv; Jie Cui; Hua-Bin Fu; Jing-Zhou Wang
Journal:  Biochem Biophys Res Commun       Date:  2006-12-18       Impact factor: 3.575

6.  Toll-like receptor 4 contributes to retinal ischemia/reperfusion injury.

Authors:  Galina Dvoriantchikova; David J Barakat; Eleut Hernandez; Valery I Shestopalov; Dmitry Ivanov
Journal:  Mol Vis       Date:  2010-09-30       Impact factor: 2.367

7.  Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury.

Authors:  Juan Pablo de Rivero Vaccari; George Lotocki; Ofelia F Alonso; Helen M Bramlett; W Dalton Dietrich; Robert W Keane
Journal:  J Cereb Blood Flow Metab       Date:  2009-04-29       Impact factor: 6.200

Review 8.  The pathophysiology and treatment of glaucoma: a review.

Authors:  Robert N Weinreb; Tin Aung; Felipe A Medeiros
Journal:  JAMA       Date:  2014-05-14       Impact factor: 56.272

Review 9.  Current understanding of the treatment and outcome of acute primary angle-closure glaucoma: an Asian perspective.

Authors:  Leslie P S Ang; Leonard P K Ang
Journal:  Ann Acad Med Singapore       Date:  2008-03       Impact factor: 2.473

Review 10.  How are the regulators regulated? The search for mechanisms that impose specificity on induction of cell death and NF-kappaB activation by members of the TNF/NGF receptor family.

Authors:  David Wallach; Thangavelu U Arumugam; Mark P Boldin; Giuseppina Cantarella; Koluman A Ganesh; Yuri Goltsev; Tanya M Goncharov; Andrew V Kovalenko; Akhil Rajput; Eugene E Varfolomeev; Si Qing Zhang
Journal:  Arthritis Res       Date:  2002-05-09
View more
  86 in total

1.  B-cell lymphoma 2 rs17757541 C>G polymorphism was associated with an increased risk of coronary artery disease in a Chinese population.

Authors:  Yang Xuan; Li-Na Wang; Ping-Min Wei; Hong Zhi; Zu-Hong Lu
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

2.  Kaempferol attenuates retinal ganglion cell death by suppressing NLRP1/NLRP3 inflammasomes and caspase-8 via JNK and NF-κB pathways in acute glaucoma.

Authors:  Chaobin Lin; Fujin Wu; Tongmei Zheng; Xiuchun Wang; Yiwei Chen; Xiaomin Wu
Journal:  Eye (Lond)       Date:  2018-12-18       Impact factor: 3.775

Review 3.  Inflammasomes in Myeloid Cells: Warriors Within.

Authors:  Sushmita Jha; W June Brickey; Jenny Pan-Yun Ting
Journal:  Microbiol Spectr       Date:  2017-01

Review 4.  Inflammasomes, the eye and anti-inflammasome therapy.

Authors:  P Yerramothu; A K Vijay; M D P Willcox
Journal:  Eye (Lond)       Date:  2017-11-24       Impact factor: 3.775

5.  A Disease-associated Mutant of NLRC4 Shows Enhanced Interaction with SUG1 Leading to Constitutive FADD-dependent Caspase-8 Activation and Cell Death.

Authors:  Akhouri Kishore Raghawan; Anand Sripada; Gayathri Gopinath; Pendyala Pushpanjali; Yatender Kumar; Vegesna Radha; Ghanshyam Swarup
Journal:  J Biol Chem       Date:  2016-12-14       Impact factor: 5.157

Review 6.  The role of Toll-like receptors in retinal ischemic diseases.

Authors:  Wen-Qin Xu; Yu-Sheng Wang
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

7.  Association of Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile with the risk of primary open angle glaucoma.

Authors:  Jose Navarro-Partida; Abril Bernardette Martinez-Rizo; Pedro Ramirez-Barrera; Jesus Bernardino Velazquez-Fernandez; Veronica A Mondragon-Jaimes; Arturo Santos-Garcia; Veronica Benites-Godinez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-02-18       Impact factor: 3.117

Review 8.  Calpain-2 as a therapeutic target for acute neuronal injury.

Authors:  Yubin Wang; Xiaoning Bi; Michel Baudry
Journal:  Expert Opin Ther Targets       Date:  2017-11-28       Impact factor: 6.902

9.  TLR4 regulates vascular smooth muscle cell proliferation in hypertension via modulation of the NLRP3 inflammasome.

Authors:  Hui-Meng Qi; Qin Cao; Qiang Liu
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

Review 10.  Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: a review of the literature.

Authors:  Karine Evangelho; Maria Mogilevskaya; Monica Losada-Barragan; Jeinny Karina Vargas-Sanchez
Journal:  Int Ophthalmol       Date:  2017-12-30       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.